Similarly Zhong et al. showed that miR-126 restoration enhances gefitinib-induced cytotoxicity in lung cancer cells [201], while Cho et al. found that the restoration of miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with EGFR-activating mutations [202]. The gene discussed is EGFR; the disease is lung cancer.